Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inotiv Inc (NOTV)

Inotiv Inc (NOTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,080
  • Shares Outstanding, K 34,353
  • Annual Sales, $ 490,740 K
  • Annual Income, $ -108,450 K
  • EBIT $ 4 M
  • EBITDA $ 65 M
  • 60-Month Beta 4.03
  • Price/Sales 0.15
  • Price/Cash Flow 1.36
  • Price/Book 0.45

Options Overview Details

View History
  • Implied Volatility 347.91% ( +34.02%)
  • Historical Volatility 232.45%
  • IV Percentile 99%
  • IV Rank 43.78%
  • IV High 766.71% on 07/19/24
  • IV Low 21.83% on 06/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 94
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 8,623
  • Open Int (30-Day) 9,764

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.52 +34.21%
on 04/21/25
2.36 -13.56%
on 05/08/25
+0.27 (+15.25%)
since 04/15/25
3-Month
1.15 +77.39%
on 04/10/25
4.51 -54.77%
on 02/20/25
-1.74 (-46.03%)
since 02/14/25
52-Week
1.15 +77.39%
on 04/10/25
6.48 -68.52%
on 12/16/24
-0.20 (-8.93%)
since 05/15/24

Most Recent Stories

More News
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

NOTV : 2.01 (-1.47%)
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

NOTV : 2.01 (-1.47%)
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system)

NOTV : 2.01 (-1.47%)
2 Stocks Insiders Are Buying and 1 They're Selling

Insider buying is a signal to buy for two of the stocks on this list, insider selling raises a red flag for the other but doesn't offset institutional activity.

NOTV : 2.01 (-1.47%)
RLI : 74.21 (+0.69%)
HLIT : 9.62 (+0.21%)
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

NOTV : 2.01 (-1.47%)
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

NOTV : 2.01 (-1.47%)
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

NOTV : 2.01 (-1.47%)
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

NOTV : 2.01 (-1.47%)
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

NOTV : 2.01 (-1.47%)
Inotiv, Inc. Announces Proposed Underwritten Public Offering of Common Shares

Inotiv, Inc. plans an underwritten public offering of its common shares, subject to market conditions.Quiver AI SummaryInotiv, Inc. has announced the launch of an underwritten public offering of its common...

NOTV : 2.01 (-1.47%)

Business Summary

Inotiv Inc. is a pharmaceutical development company. It involved in providing contract research services and monitoring instruments to emerging pharmaceutical companies. Inotiv Inc., formerly known as Bioanalytical Systems Inc., is based in WEST LAFAYETTE, Ind.

See More

Key Turning Points

3rd Resistance Point 2.24
2nd Resistance Point 2.17
1st Resistance Point 2.10
Last Price 2.01
1st Support Level 1.97
2nd Support Level 1.90
3rd Support Level 1.83

See More

52-Week High 6.48
Fibonacci 61.8% 4.44
Fibonacci 50% 3.82
Fibonacci 38.2% 3.19
Last Price 2.01
52-Week Low 1.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar